Physical Therapy Delivery Models for Long-Term Parkinsons Disease Management
帕金森病长期管理的物理治疗实施模型
基本信息
- 批准号:9259348
- 负责人:
- 金额:$ 6.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract:
Parkinson's disease is a chronic, complex neurologic condition that causes progressive declines in activity
level, walking, and balance. These mobility impairments are associated with worse quality of life and mortality.
Physical therapy (PT) has been shown to effectively treat these mobility problems, and exercise is associated
with better quality of life and increased physical activity. Evidence-based PT guidelines for people with
Parkinson's disease have been developed to support mobility and exercise participation across all disease
severities, but our preliminary data indicates that PT is used inconsistently in the United States (US). The two
research objectives of this F32 postdoctoral fellowship are (1) to describe current PT practice in the US and
evaluate the extent to which it reflects the existing evidence-based guidelines, and then (2) to determine
barriers and facilitators to the delivery of evidence-based PT from patient and provider perspectives. Objective
1 will survey expert physician/referrers and expert physical therapists for people with Parkinson's disease to
describe their PT-related referral and practice decisions across the stages of the disease. The results of this
survey will be mapped onto existing guidelines to evaluate conformity with evidence-based practice. Objective
2 will use focus groups and key informant interviews of people with Parkinson's disease, physical therapists,
and physicians to explain how current practice is similar or different from evidence-based practice. The focus
group and interview questions will probe for barriers and facilitators to the delivery of evidence-based PT
services within the US healthcare context. The results of these studies promote improved synthesis of
evidence into healthcare delivery and form the basis for future implementation or knowledge translation efforts
to improve the quality of PT delivery. These research goals are aligned with AHRQ's 2014-2018 Strategic Plan
goal 1B to “improve healthcare quality,” goal 1E to ensure access to “quality, culturally competent care,
including long-term services and supports for vulnerable populations,” and goal 3C to “improve the accessibility
and quality of supportive services for people with disabilities and older adults.” The final outcomes of these
studies are to develop implementation strategies to improve the delivery of high-quality, evidence-based PT for
people with Parkinson's disease.
项目概要/摘要:
帕金森氏病是一种慢性、复杂的神经系统疾病,会导致活动进行性下降
水平、行走和平衡。这些行动障碍与生活质量和死亡率下降有关。
物理治疗(PT)已被证明可以有效地治疗这些流动性问题,运动与此相关。
生活质量更好,身体活动增加。循证PT指南
帕金森病已经发展到支持所有疾病的流动性和运动参与
严重程度,但我们的初步数据表明,PT在美国(US)的使用并不一致。两
这个F32博士后奖学金的研究目标是(1)描述美国目前的PT实践,
评估其反映现有循证指南的程度,然后(2)确定
从患者和提供者的角度来看,提供循证PT的障碍和促进因素。目的
1将调查专家医生/专家和专家物理治疗师为帕金森病患者,
描述他们在疾病各阶段的PT相关转诊和实践决策。的结果
调查将与现有准则相对应,以评价是否符合循证实践。目的
2将使用焦点小组和帕金森病患者,物理治疗师,
和医生解释如何目前的做法是相似的或不同的循证实践。重点
小组和访谈问题将探讨提供循证PT的障碍和促进因素
在美国的医疗保健领域。这些研究的结果促进了合成的改进。
将证据纳入医疗保健服务,并为未来的实施或知识转化工作奠定基础
提高PT交付质量。这些研究目标与AHRQ的2014-2018年战略计划保持一致
目标1B是“提高医疗质量”,目标1 E是确保获得“高质量、文化上合格的医疗服务,
包括为弱势群体提供长期服务和支助”,以及目标3C“改善
以及为残疾人和老年人提供的支助服务的质量。”这些活动的最终结果
研究旨在制定实施策略,以改善高质量,循证PT的提供,
帕金森氏症患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miriam Rose Rafferty其他文献
Miriam Rose Rafferty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miriam Rose Rafferty', 18)}}的其他基金
Consultative Physical Therapy: A Physical Activity and Exercise Implementation Strategy in Parkinson's
咨询物理治疗:帕金森病的身体活动和锻炼实施策略
- 批准号:
10565287 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Physical Therapy Delivery Models for Long-Term Parkinsons Disease Management
帕金森病长期管理的物理治疗实施模型
- 批准号:
9352689 - 财政年份:2016
- 资助金额:
$ 6.89万 - 项目类别:
相似海外基金
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 6.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
EPR-effect driven tumor delivery of multifunctional boron nanomedicine for neutron capture therapy
EPR效应驱动的多功能硼纳米药物的肿瘤递送用于中子捕获治疗
- 批准号:
22KF0311 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis
口服可溶纸条(ODS)作为潜伏性结核病治疗的新儿科和成人给药方式
- 批准号:
10760389 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy
新型在线平台提供先进的药物输送装置,用于优化糖尿病治疗
- 批准号:
10736126 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Pulmonary delivery of base editors for gene therapy of cystic fibrosis with nonsense mutations
肺部递送碱基编辑器用于无义突变囊性纤维化的基因治疗
- 批准号:
488681 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Operating Grants
Efficient, controlled delivery of synthetic anion carriers to epithelial cells for CFTR replacement therapy
高效、受控地将合成阴离子载体递送至上皮细胞,用于 CFTR 替代疗法
- 批准号:
2904232 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Studentship
ICF: Hollow-fiber bioreactor technology to explore mechanisms and delivery of cellular therapy during machine perfusion of donated human kidneys
ICF:中空纤维生物反应器技术,用于探索捐献人肾脏机器灌注过程中细胞治疗的机制和实施
- 批准号:
MR/Y000676/1 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Fellowship
Development of innovative MSC-based therapy based on intracellular mitochondrial delivery methods
基于细胞内线粒体递送方法开发基于 MSC 的创新疗法
- 批准号:
23H03749 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Lens-mediated Delivery of Therapy for Dry Eye Disease
I-Corps:晶状体介导的干眼病治疗
- 批准号:
2348174 - 财政年份:2023
- 资助金额:
$ 6.89万 - 项目类别:
Standard Grant